Christopher P. Holmes,Qun Yin,Guy Lalonde,Peter J. Schatz,David Tumelty,Balu Palani,Genet Zemede
申请号：
US13654507
公开号：
US20130130979A1
申请日:
2012.10.18
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.
